The 89th Annual Meeting of the Japanese Society of Hematology【Fukuoka Prefecture】
The 89th Annual Meeting of the Japanese Society of Hematology (JSH2027) will take place October 8–10, 2027 (Friday–Sunday), at Fukuoka International Congress Center and Marine Messe Fukuoka Halls A and B in Fukuoka, Japan. The meeting theme is “Where Possibilities Blossom” (English translation of 可能性が花開く場所). The meeting president is Dr. Kazuya Shimoda of the University of Miyazaki Faculty of Medicine. The meeting covers hematology from basic and clinical research to diagnosis and treatment. Relevant fields include leukemia, malignant lymphoma, multiple myeloma, hematopoietic stem cell transplantation, cell therapy and molecular diagnostics. The meeting will be held in person, with selected programs planned for subsequent on-demand streaming.
Meeting Theme and Objectives
Where Possibilities Blossom
Official Japanese theme: 可能性が花開く場所. The English wording is a translation for this event listing.
The meeting president’s message emphasizes both advancing hematology research and sharing knowledge that can improve everyday clinical practice. Translating new insights into disease mechanisms into diagnostic and therapeutic applications is central to improving patient outcomes and quality of life.
The meeting also aims to foster new research ideas and collaborations across scientific disciplines and generations, creating opportunities for early-career researchers and physicians to contribute to the future of hematology.
Official information: Meeting President’s Message (Japanese)
89th Annual Meeting of the Japanese Society of Hematology: Event Information
- Official English Name: The 89th Annual Meeting of the Japanese Society of Hematology.
- Official Japanese Name: 第89回日本血液学会学術集会.
- Dates: October 8–10, 2027 (Friday–Sunday).
- Venues: Fukuoka International Congress Center and Marine Messe Fukuoka Halls A and B.
- Location: Hakata-ku, Fukuoka, Japan.
- Organizer: Japanese Society of Hematology (JSH).
- Meeting Theme: Where Possibilities Blossom (English translation).
- Meeting Format: In-person, with selected programs planned for subsequent on-demand streaming.
- Official Website Launch: October 26, 2026.
Official information: Meeting Overview and Format (Japanese) / JSH Annual Meeting Schedule (Japanese)
Meeting Organization
Meeting President: Dr. Kazuya Shimoda, Professor, Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine.
Dr. Shimoda’s research interests include hematology and medical oncology. The hematology department at University of Miyazaki Hospital provides chemotherapy, molecularly targeted therapies and hematopoietic stem cell transplantation for relevant hematological diseases.
- Scientific Program Committee Chair: Dr. Toshihiro Miyamoto (Kanazawa University).
- Committee Vice Chairs: Dr. Yoshikane Kikushige (Kyushu University) and Dr. Noriko Fukuhara (Tohoku University Hospital).
- Organizing Secretariat: Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine.
- Address: 5200 Kihara, Kiyotake-cho, Miyazaki, Miyazaki 889-1692, Japan.
- Administrative Secretariat: Japan Convention Services, Inc., Kansai Branch.
- Address: Keihanshin Yodoyabashi Building 2F, 4-4-7 Imabashi, Chuo-ku, Osaka 541-0042, Japan.
- Email: 89jsh@convention.co.jp
Official information: Scientific Program Committee and Secretariat (Japanese) / University of Miyazaki: Dr. Kazuya Shimoda Research Profile (Japanese)
Key Research Areas and Highlights
The following are representative research and clinical areas in hematology. They do not constitute a confirmed list of presentations or sessions at the 89th annual meeting.
- Hematological Malignancies: Disease mechanisms, diagnosis and treatment of acute and chronic leukemias, malignant lymphomas, multiple myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
- Hematopoietic Stem Cell and Blood Cell Biology: Stem cell self-renewal, differentiation, regulation of hematopoiesis, the bone marrow microenvironment and mechanisms of hematological malignancy development.
- Molecular Diagnostics and Genomic Medicine: Mutation analysis, chromosomal abnormalities, molecular biomarkers, next-generation sequencing (NGS) and measurable residual disease (MRD) assessment.
- Hematopoietic Stem Cell Transplantation and Transplant Immunology: Allogeneic and autologous transplantation, HLA matching, graft-versus-host disease (GVHD), immune reconstitution and long-term management.
- Cell Therapy and Immunotherapy: CAR T-cell therapy, therapeutic antibodies, bispecific antibodies and immune cell functional assessment.
- Nonmalignant Hematological Disorders: Diagnosis and treatment of anemia, bone marrow failure, platelet disorders, thrombosis, hemostasis and coagulation abnormalities.
- Drug Discovery and Translational Research: Novel therapeutic targets, drug response, treatment resistance and translation of basic research into clinical applications.
Pharma Nexus highlights: Relevant technologies include flow cytometry, nucleic acid extraction, PCR, NGS, cell culture, cell manufacturing, cryopreservation, drug screening, multiplex immunofluorescence and spatial proteomics. Technologies for studying cellular composition and cell-cell interactions within the bone marrow microenvironment are particularly relevant to research on hematological disease mechanisms and treatment resistance. These are related research technologies, not confirmed exhibits or validated clinical diagnostic applications at the 89th annual meeting.
Official information: Japanese Society of Hematology: Scientific and Research Resources (Japanese) / University of Miyazaki Hospital: Hematology (Japanese)
Call for Abstracts and Research Presentations
The official abstract submission page for the 89th annual meeting is available, but submission guidelines remain under preparation.
- Abstract Submission Opening Date and Deadline: Under preparation.
- Eligibility, Abstract Categories and Formatting Requirements: Under preparation.
- Presentation Formats and Languages: Details not confirmed.
- Acceptance Notifications and Presenter Registration Requirements: Under preparation.
- General Abstract Inquiries: ab-89jsh@senkyo.co.jp
Scientific Presentation Policies: In an official notice dated September 29, 2026, JSH announced that it is developing rules of conduct for meeting participants and a copyright policy for abstracts and presentation materials, with implementation planned from the 89th annual meeting. Prospective presenters and attendees should consult the final policies and official abstract submission guidelines.
Official information: Call for Abstracts (Japanese) / Notice on Participant Conduct and Copyright Policies (Japanese)
Scientific Program and Schedule
The 2027 scientific program committee has been announced. However, the detailed scientific program, special lectures, symposia, general presentations and speakers remain under preparation.
- Meeting Dates: October 8–10, 2027.
- International Invited Speakers and Detailed Program: Under preparation.
- Clinical Debate: Under preparation.
- Scientific Exchange Training Program (SETP): Under preparation.
- Patient Participation Program: Under preparation.
- On-Demand Streaming: Selected programs are planned for subsequent streaming. Availability dates and eligible programs have not been announced.
Please consult forthcoming announcements for individual sessions, speakers and participation requirements. Full online access or live streaming of every session should not be assumed.
Official information: Scientific Program (Japanese) / Clinical Debate / SETP / Patient Participation Program (Japanese)
Registration, Fees and Accommodation
Registration details for the 89th Annual Meeting of the Japanese Society of Hematology remain under preparation. Registration periods, fees and registration categories have not been announced.
- Advance and On-Site Registration: Under preparation.
- Registration Fees and Membership Categories: Under preparation.
- Student and Nonmember Participation Requirements: Details not confirmed.
- Specialist Certification Credits and Streaming Access: Details not confirmed.
Accommodation (updated November 9, 2026): The official meeting website provides information on a dedicated Rakuten Travel booking page for meeting participants. Hotel availability, rates and cancellation conditions should be checked at the time of booking.
Official information: Registration (Japanese) / Accommodation and Participant Booking Information (Japanese)
Corporate Sponsorship and Exhibition Opportunities
The corporate partner application page for the 89th annual meeting remains under preparation. However, official contact details for corporate partners, advertising and book exhibitions have been published.
- Corporate Partner Applications: Under preparation.
- Corporate Exhibitions, Sponsored Seminars and Advertising: Application requirements not confirmed.
- Application Deadlines, Sponsorship Fees and Booth Specifications: Under preparation.
- Exhibition Dates and Move-in/Move-out Schedule: Details not confirmed.
- Corporate Partner Inquiries: sp-89jsh@jcs-c.com
- Advertising and Book Exhibition Inquiries: 89jsh@convention.co.jp
Relevant Industries: Hematological disease therapeutics, antibody therapeutics, cell therapy and regenerative medicine, blood testing instruments and reagents, flow cytometry, molecular diagnostics, genetic analysis, cell culture, cell manufacturing, cryopreservation and research support services.
These are related industry sectors, not an official list of eligible exhibitors. Please consult the forthcoming official sponsorship guidelines for exhibition arrangements, application requirements and available sponsorship packages.
Official information: Corporate Partner Applications (Japanese) / Sponsorship, Advertising and Book Exhibition Inquiries (Japanese)
Venues and Access
Fukuoka International Congress Center
2-1 Sekijomachi, Hakata-ku, Fukuoka 812-0032, Japan
Marine Messe Fukuoka Hall A
7-1 Okihamamachi, Hakata-ku, Fukuoka 812-0031, Japan
Marine Messe Fukuoka Hall B
2-1 Okihamamachi, Hakata-ku, Fukuoka 812-0031, Japan
- From Hakata Station: Take a Nishitetsu bus to Kokusai Kaigijo/Sun Palace-mae or Marine Messe-mae.
- From Tenjin: Take a Nishitetsu bus to Kokusai Kaigijo/Sun Palace-mae or Marine Messe-mae.
- From Gofukumachi Subway Station: Approximately 12 minutes on foot to Fukuoka International Congress Center or 15 minutes to Marine Messe Fukuoka Hall A.
- From Fukuoka Airport: Take the Fukuoka City Subway to Hakata Station and transfer to a bus serving the venues.
The meeting will use three facilities. Please consult forthcoming official announcements for venue assignments for registration, scientific sessions and exhibitions, as well as any meeting-specific transportation arrangements.
Official information: Fukuoka International Congress Center / Marine Messe Fukuoka Hall A / Marine Messe Fukuoka Hall B
Official Websites
89th Annual Meeting of the Japanese Society of Hematology Official Website (Japanese)
Meeting Overview and Format (Japanese)
Meeting President’s Message (Japanese)
Corporate Partner Applications (Japanese)
Accommodation Information (Japanese)
Meeting Secretariat and Inquiries (Japanese)
Japanese Society of Hematology Official Website
Information checked November 13, 2026. Meeting dates, venues, president, theme, format and accommodation information are based on official announcements for the 89th annual meeting. Abstract submissions, registration, the detailed scientific program and corporate partner applications remain under preparation. Please consult the official meeting website for the latest information.
